SCHEMBL24136647

SCHEMBL24136647

COc1c(C)c2c(c(Cl)c1OC)C(=O)NCC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 6/20 0.35
▸ PARP11 Q9NR21 6/20 0.35
▸ PARP1 P09874 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MTNR1A P48039 1/20 0.34
▸ MTNR1B P49286 1/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ IMPDH2 P12268 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ PTK2B Q14289 1/20 0.32
▸ DAPK3 O43293 1/20 0.31
▸ DYRK3 O43781 1/20 0.31
▸ MAP4K4 O95819 1/20 0.31
▸ CDK1 P06493 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30046575 1.00 PARP10 (0.35) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL24136727 0.79 IMPDH2 (0.37) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL30466436 0.75 ACHE (0.39) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL24136596 0.75 ACHE (0.39) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL14854352 0.74 DYRK1A (0.43) PARP10PARP1ALDH1A1NCOA1NCOA3
SCHEMBL15814278 0.73 NCOA1 (0.43) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL15830723 0.70 PARP10 (0.44) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL19229259 0.70 KDR (0.40) PARP10PARP1KDM4EALDH1A1MAPT
SCHEMBL24136595 0.69 ACHE (0.39) PARP10PARP11PARP1KDM4EALDH1A1
SCHEMBL23978726 0.69 PARP1 (0.41) PARP10PARP11PARP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535629-B2 Dioxoloisoquinolinone derivatives and use thereof HANMI PHARMACEUTICAL CO., LTD. (KR) 2022-12-27 — — US disclosed
US-20220135582-A1 NOVEL HETEROTRICYCLIC DERIVATIVE COMPOUND AND USE OF SAME HANMI PHARMACEUTICAL CO., LTD. (KR) 2022-05-05 — — US disclosed
EP-3929199-A1 NOVEL HETEROTRICYCLIC DERIVATIVE COMPOUND AND USE OF SAME Hanmi Pharmaceutical Co., Ltd. (KR) 2021-12-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11535629-B2 Dioxoloisoquinolinone derivatives and use thereof EZH2, EZH1, EED PARP10 870/4885PARP11 1087/4885PARP1 1387/4885
US-20220135582-A1 NOVEL HETEROTRICYCLIC DERIVATIVE COMPOUND AND USE OF SAME EZH2, EZH1, BMI1 PARP10 499/4885PARP11 327/4885PARP1 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback